Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Chronic primary central nervous system histoplasmosis in a healthy child with intermittent neurological manifestations.
Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS).
Spasticity in multiple sclerosis: results of a patient survey.
Resistance training and vibration improve muscle strength and functional capacity in female patients with multiple sclerosis.
[2012: news in neurology].
New Data Show Longer Tysabri Dosing Interval in MS Is Feasible
Interleukin-10 expression during the acute phase is a putative prerequisite for delayed viral elimination in a murine model for multiple sclerosis.
Autologous hematopoietic stem cell transplantation for multiple sclerosis - if confused or hesitant, remember: 'Treat with standard immune suppressive drugs and if no inflammation, no response'.
Epileptic Seizures in Early-onset Multiple Sclerosis.
Exome sequencing to find rare variants causing neurologic diseases.
A mechanism-based classification of pain in multiple sclerosis.
Human Umbilical Cord Mesenchymal Stem Cell Therapy on Neuromyelitis Optica.
No additional copies of HERV-Fc1 in the germ line of multiple sclerosis patients.
Personalized medicine in multiple sclerosis: hope or reality?
Sample size estimation for negative binomial regression comparing rates of recurrent events with unequal follow-up time.
Estimating typical multiple sclerosis disability progression speed from clinical observations.
Patients with multiple sclerosis show increased oxidative stress markers and somatic telomere length shortening.
Natalizumab discontinuation in patients with multiple sclerosis: Profiling risk and benefits at therapeutic crossroads.
Health-related quality of life and economic impact of urinary incontinence due to detrusor overactivity associated with a neurologic condition: a systematic review.
Exercise, brain, and cognition across the life span.
DSM-III disorders from age 11 to age 15 years.
Statin treatment of adult human glial progenitors induces PPAR gamma-mediated oligodendrocytic differentiation.
Devic's disease before Devic: Bilateral optic neuritis and simultaneous myelitis in a young woman (1874).
Early accurate diagnosis crucial in multiple sclerosis.
Modulators of Microglia: a Patent Review.
Pages
« first
‹ previous
…
311
312
313
314
315
316
317
318
319
…
next ›
last »